Close this search box.
Blog » News » $2.25 billion Bayer chemical verdict reduced to $400 million by Judge

$2.25 billion Bayer chemical verdict reduced to $400 million by Judge

A weed killer can with a skull and crossbones in a miniature style

Judge Susan Schulman granted a reduced penalty to Bayer from $2.25 billion to $400 million in an ongoing court case.

A Pennsylvania man, who took on the chemical giant in a legal battle has been awarded a reduced sum after a meteoric win in the Philadelphia Court of Common Pleas.

The man argued that he developed cancer due to exposure to the weed killer Roundup. He held Bayer responsible, and he was initially awarded the billion-dollar payout.

Bayer complaints of false Testimony approved.

The chemical company took its complaint to the Superior Court of Pennsylvania, saying the appeal to the decision was based on misleading information. In the courtroom, Bayer complained that the initial court hearing was biased because the jury was exposed to misleading and inflammatory testimony.

At the time of the initial verdict, Bayer was adamant, saying, “With the jury’s adverse verdict that conflicts with the overwhelming weight of scientific evidence and worldwide regulatory and scientific assessments, and believe that we have strong arguments on appeal to get this verdict overturned and the unconstitutionally excessive damage award eliminated or reduced.”

The post-trial verdict, heard by Judge Susan Schulman, would slice the compensatory damages to $50 million and punitive damages to $350 million, a massive win for Bayer.

Bayer released a statement on their site, detailing their massive clawback in this nationwide case.

The company said, “While the court’s decision reduces the unconstitutionally excessive damage award, we still disagree with the ruling on the liability verdict, as the trial was marred by significant and reversible errors that misled and inflamed the jury. There is no other explanation for the excessive damage awards. These errors reinforce the urgent need for legislative reform to clarify that compliance with labels required under federal law is sufficient to meet all state warning requirements.”

The $63 billion purchase of U.S. agrochemical company Monsanto in 2018 has bit Bayer massively, with the company having to deal with multiple injury and health complaints.

165,000 claims have been made in the United States against Monsanto, and Bayer since taking over have quashed the bulk of them. Still this is still a bloody nose for the German-based company and one that will set precedent in the trials to follow.

Image: Ideogram.

About Due’s Editorial Process

We uphold a strict editorial policy that focuses on factual accuracy, relevance, and impartiality. Our content, created by leading finance and industry experts, is reviewed by a team of seasoned editors to ensure compliance with the highest standards in reporting and publishing.

Financial News Writer and Editor
Brian-Damien Morgan, an accomplished journalist and features writer, boasts a rich career that has evolved across various media platforms. With extensive experience in the print sector of several UK newspapers, Brian transitioned seamlessly into the realm of digital broadcasting and specialized financial content creation. Brian now focuses on finance, technology, legal matters, and the wide spectrum of money-related topics.

About Due

Due makes it easier to retire on your terms. We give you a realistic view on exactly where you’re at financially so when you retire you know how much money you’ll get each month. Get started today.


Top Trending Posts

Due Fact-Checking Standards and Processes

To ensure we’re putting out the highest content standards, we sought out the help of certified financial experts and accredited individuals to verify our advice. We also rely on them for the most up to date information and data to make sure our in-depth research has the facts right, for today… Not yesterday. Our financial expert review board allows our readers to not only trust the information they are reading but to act on it as well. Most of our authors are CFP (Certified Financial Planners) or CRPC (Chartered Retirement Planning Counselor) certified and all have college degrees. Learn more about annuities, retirement advice and take the correct steps towards financial freedom and knowing exactly where you stand today. Learn everything about our top-notch financial expert reviews below… Learn More